Our funding is from the ARC, the NHMRC, US Food and Drug Administration and AgriFutures Australia.


Our active collaborators are:

  • AIBN, UQ
  • Basil Hetzel Institute and University of South Australia in Adelaide 
  • Centre of Clinical Research, UQ
  • China Pharmaceutical University
  • Department of General Surgery, Changzheng Hospital, The Second Military Medical University, Shanghai, China
  • Diamantina Institute in TRI
  • QUT in TRI
  • Simcyp Division of Certara UK Pty Ltd
  • South Asian Clinical Toxicology Research Collaboration, Sri Lanka
  • Translational Australian Clinical Toxicology (TACT) program at the University of Sydney
  • UNIFESP-Diadema – Brasil
  • University of California, San Franscisco
  • University of Manitoba, Canada
  • University of Newcastle, Australia
  • University of NSW
  • US Food & Drug Administration